Hims & Hers Health Q2 FY26: revenue $753.2M, up 38%; diluted EPS −$0.37

Key figures from this report

These are the numbers Hims & Hers Health reported for Q2 FY26, the quarter ended Jun 30, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$753.2M+38% from $544.8M in Q2 FY2510-Q income statement, on EDGAR
2. Net income−$86.3M−303% from $42.5M in Q2 FY2510-Q income statement, on EDGAR
3. Diluted EPS−$0.37−318% from $0.17 in Q2 FY2510-Q income statement, on EDGAR
4. Cash and cash equivalents$609.8M−46% from $1.1B in Q2 FY25Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
5. Cash from operations−$35.9MAgainst −$19.1M in Q2 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables